Al's Comment:

 Hopefully this will speed up the FDA approval process for Onc-201. This drug should have been approved last year. 

---

Posted on: 01/08/2021

Chimerix places its bets on Oncoceutics' dopamine antagonist for rare brain cancer in quest to salvage its image

 

---

Click HERE to return to brain tumor news headlines.